肝脏研究（英文）2025，Vol.9Issue(2)：94-103,10.DOI:10.1016/j.livres.2025.01.001
New drug therapies for metabolic dysfunction-associated steatohepatitis
New drug therapies for metabolic dysfunction-associated steatohepatitis
摘要
关键词
Bile acids/Farnesoid X receptor(FXR)/Takeda G protein-coupled receptor 5(TGR5)/Glucagon-like peptide-1(GLP-1)/Metabolic dysfunction-associated steatotic liver disease(MASLD)/Metabolic dysfunction-associated steatohepatitis(MASH)Key words
Bile acids/Farnesoid X receptor(FXR)/Takeda G protein-coupled receptor 5(TGR5)/Glucagon-like peptide-1(GLP-1)/Metabolic dysfunction-associated steatotic liver disease(MASLD)/Metabolic dysfunction-associated steatohepatitis(MASH)引用本文复制引用
John Y.L.Chiang..New drug therapies for metabolic dysfunction-associated steatohepatitis[J].肝脏研究（英文）,2025,9(2):94-103,10.基金项目
This work was supported by National Institutes of Health(NIH)grants DK44442 and DK58379. （NIH）
